Biofisica, a high tech wound care company, has obtained a commitment of $2.3 million in financing from investors. The funding will support Biofisica's continued marketing efforts in the UK and ongoing planning initiatives in the US.
Subscribe to our email newsletter
The round was led by Unilever Technology Ventures, Novartis Venture Funds, the ATDC Seed Capital Fund, as well as a number of private investors.
Rafael Andino, founder of Biofisica, said: “We are very pleased that our investors continue to show a tremendous vote of confidence for the progress that we’re making with our business plan and the recognition that POSiFECT serves a critical need in the wound care market.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.